MarketCap
Facebook
X
TelegramCronos Group ROCE 2011-2025 | CRON
ROCE Jährlich Cronos Group
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | -10.43 | -6.59 | -8.4 | 2.99 | -5.0 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.99 | -10.43 | -5.49 |
ROCE anderer Aktien in der Arzneimittelhersteller
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
-24.04 | $ 1.21 | -7.63 % | $ 130 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
-190.63 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
DURECT Corporation
DRRX
|
-249.5 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Aurora Cannabis
ACB
|
-23.09 | $ 4.47 | -2.08 % | $ 86.3 M | Canada |
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Zomedica Corp.
ZOM
|
-13.16 | - | -0.21 % | $ 98 M | USA |
 |
Evoke Pharma
EVOK
|
-184.26 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-39.6 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-85.61 | - | 2.45 % | $ 38.1 M | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |
 |
Emergent BioSolutions
EBS
|
-111.87 | $ 12.36 | -2.37 % | $ 633 M | USA |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | $ 21.6 | 0.07 % | $ 2.06 B |  France |
 |
Evolus
EOLS
|
-623.16 | $ 6.88 | 0.36 % | $ 427 M | USA |
 |
Harrow Health
HROW
|
0.61 | $ 50.08 | -0.16 % | $ 1.63 B | USA |
 |
China Pharma Holdings
CPHI
|
-59.23 | $ 1.29 | -1.56 % | $ 22.5 M |  China |
 |
Neoleukin Therapeutics
NLTX
|
-29.88 | - | - | $ 193 M | Canada |
 |
OrganiGram Holdings
OGI
|
-35.84 | $ 1.8 | 1.99 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
-94.23 | $ 7.19 | -0.07 % | $ 2.62 B | Canada |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
Organogenesis Holdings
ORGO
|
-0.49 | $ 5.36 | -8.71 % | $ 706 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.06 | $ 4.11 | -2.14 % | $ 57.8 M | USA |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 26.48 | 1.77 % | $ 1.22 B | USA |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.75 | -1.13 % | $ 3.37 M | Canada |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
1.31 | $ 13.87 | 0.95 % | $ 1.91 B | USA |
 |
ProPhase Labs
PRPH
|
32.97 | $ 0.51 | -16.94 % | $ 8.08 M | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-121.49 | $ 4.5 | -2.21 % | $ 135 M | USA |
 |
Rockwell Medical
RMTI
|
-31.33 | $ 0.87 | 7.18 % | $ 20.3 M | USA |
 |
OptiNose
OPTN
|
26.27 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-176.47 | $ 9.92 | 0.22 % | $ 705 M | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-81.9 | $ 5.83 | -1.19 % | $ 238 M | USA |
 |
SCYNEXIS
SCYX
|
99.6 | $ 0.58 | -1.87 % | $ 27.8 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-84.11 | $ 3.63 | -0.41 % | $ 4.5 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
-41.31 | $ 9.6 | -5.43 % | $ 5.93 B | Canada |
 |
TherapeuticsMD
TXMD
|
-29.1 | $ 1.72 | 0.88 % | $ 18 M | USA |
 |
Veru
VERU
|
-114.23 | $ 2.37 | 1.28 % | $ 320 M | USA |
 |
Viatris
VTRS
|
7.66 | $ 12.33 | 0.69 % | $ 14.9 B | USA |